Process Development for the Synthesis of BI 1702135: A Concise Design Enabled by Selective Acylation of a 2-Aminobenzimidazole Intermediate
- 5 April 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (4) , 788-797
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- SMARCA4 and SMARCA2 deficiency in non–small cell lung cancer: immunohistochemical survey of 316 consecutive specimensAnnals of Diagnostic Pathology, 2017
- Small‐Molecule PROTACS: New Approaches to Protein DegradationAngewandte Chemie International Edition, 2016
- Phthalimide conjugation as a strategy for in vivo target protein degradationScience, 2015
- Catalytic in vivo protein knockdown by small-molecule PROTACsNature Chemical Biology, 2015
- Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) MutationMolecular and Cellular Biology, 2014
- Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersProceedings of the National Academy of Sciences, 2014
- A Synthetic Lethality–Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1Cancer Research, 2013
- The Spectrum of SWI/SNF Mutations, Ubiquitous in Human CancersPLOS ONE, 2013
- The SWI/SNF complex and cancerOncogene, 2009
- Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancerEpigenetics, 2008